These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23278364)

  • 21. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.
    Mucalo I; Jovanovski E; Rahelić D; Božikov V; Romić Z; Vuksan V
    J Ethnopharmacol; 2013 Oct; 150(1):148-53. PubMed ID: 23973636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
    Weber MA; Bakris GL; Dahlöf B; Pitt B; Velazquez E; Gupte J; Lefkowitz M; Hester A; Shi V; Weir M; Kjeldsen S; Massie B; Nesbitt S; Ofili E; Jamerson K
    Blood Press; 2007; 16(1):13-9. PubMed ID: 17453747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival after myocardial infarction in patients with type 2 diabetes.
    Zia S; Hasan ZU
    J Pak Med Assoc; 2004 Feb; 54(2):73-80. PubMed ID: 15134207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
    Kengne AP; Czernichow S; Huxley R; Grobbee D; Woodward M; Neal B; Zoungas S; Cooper M; Glasziou P; Hamet P; Harrap SB; Mancia G; Poulter N; Williams B; Chalmers J;
    Hypertension; 2009 Aug; 54(2):399-404. PubMed ID: 19470869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: the LIFE Study.
    Okin PM; Hille DA; Wiik BP; Kjeldsen SE; Lindholm LH; Dahlöf B; Devereux RB
    Diabet Med; 2013 Oct; 30(10):1189-97. PubMed ID: 23587029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
    Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K
    Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
    Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
    Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
    Fu SN; Luk W; Wong CK; Cheung KL
    J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
    Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus.
    Laugesen E; Rossen NB; Poulsen PL; Hansen KW; Ebbehøj E; Knudsen ST
    J Hum Hypertens; 2012 Mar; 26(3):164-70. PubMed ID: 21390057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.